Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020473 (
hyperlipidemia
)
15,891
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Takeda Pharmaceutical Co Ltd is developing
TAK
-475, a squalene synthetase inhibitor from a series of 4,1-benzoxazepine-3-acetic acid derivatives, for the potential oral treatment of
hyperlipidemia
. By March 2005,
TAK
-475 was undergoing phase III clinical trials in the US and Europe.
...
PMID:Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia. 1700 64
